Proscalpin 1mg tablet contains Finasteride 1 mg is used to relieve symptoms of elarged prostate gland (benign prostatic hyperplasia or BPH). It is also used for treatment of male pattern hair loss (androgenetic alopecia). Proscalpin 1mg is in a class of medications called 5-alpha reductase inhibitors. Proscalpin 1mg or Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used to treat hair loss.
| Pack Size | Qty | Price | Unit Price | |
|---|---|---|---|---|
| 90 Tablet/s |
|
$ 22.00 | $ 0.25 | |
| 60Tablet/s |
|
$ 16.00 | $ 0.27 | |
| 30 Tablet/s |
|
$ 10.00 | $ 0.34 |
Buy Generic Proscalpin 1mg Online at best prices
Proscalpin 1mg from India is a supplement to Finasteride 1 mg. Proscalpin 1mg Capsules are used to alleviate an enlarged prostate gland (benign prostatic hyperplasia, also known as BPH). It can also be used in the treating male-specific hair loss (androgenetic Alopecia)
Order Proscalpin 1mg can be used to treat male suffering from men who suffer from male-pattern hair loss. Proscalpin 1mg USA is used to boost hair growth on the scalp and keep hair loss from happening. Hair loss in the male pattern (also known as androgenetic hair loss) is a condition that is common where men suffer from hair loss on their scalp.
Proscalpin 1mg Online effectively decreases the amount of essential body hormone (DHT). The reduction in DHT causes more hair growth and a slower rate of loss of hair. Hair growth in other parts of the body isn't affected by finasteride. Women and children shouldn't take the medicine.
Finasteride can be typically safe for you to use for long periods. Many people use it for several months or even years without any issues. There are reports of breast cancers in men taking finasteride, but this is extremely rare.
Proscalpin 1mg Tablets has been linked to sexual side effects that could persist even after discontinuation of the drug.
John Buckley
effective medicine It promotes hair regrowth. Moreover, it also enhances hair strength I like this product price .
